INTRODUCTION
============

Therapeutic monoclonal antibodies are a genre of biopharmaceuticals which has benefitted healthcare in various fields from oncology to immune and inflammatory disorders. Development of successful novel therapeutic antibodies requires understanding of drug and disease mechanisms and the ability to stabilize, affinity mature, and humanize antibodies. Antibody structures can help overcome these challenges by providing atomic level insights into structure--function relationships and the antibody--antigen interaction \[e.g. see refs. ([@B1; @B2; @B3; @B4])\]. However, experimental techniques for obtaining antibody structures, like X-ray crystallography and nuclear magnetic resonance, are laborious, time consuming and costly. Computational antibody structure prediction provides a fast and inexpensive route to obtain structures, including those which are not obtainable otherwise.

Two antibody variable region (F~V~) modeling servers are available on the Internet: the Web Antibody Modeling (WAM) ([@B5]) and Prediction of Immunoglobulin Structure (PIGS) ([@B6]) servers. WAM can require several days to output one antibody model in response to a submitted query sequence. No information on templates used for modeling the antibody is provided. Furthermore, antibody structures predicted with WAM have internal clashes and their inaccuracies can confound computational docking ([@B2],[@B7]). The PIGS server returns an antibody model in about a minute and displays the antibody crystal structures that it selects as templates. The PIGS models are generated by grafting complementarity determining region (CDR) loops onto selected framework templates, even for the hyper-variable and non-canonical CDR H3 loop. Accurate CDR H3 predictions would only be expected when a similar CDR H3 loop is present in the database, which is unlikely for novel antibody sequences. The existing servers do not provide high-resolution refinement of antibody structures and do not consider thermodynamics during modeling.

RosettaAntibody ([@B7]) is a homology modeling program within the Rosetta suite ([@B8]) for predicting high-resolution antibody F~V~ structures. The prediction includes modeling CDR H3 loop conformations, and it uses a simple free energy function to relieve steric clashes by simultaneously optimizing the CDR loop backbone dihedral angles, the relative orientation of the light (*V*~L~) and heavy (*V*~H~) chains, and the side chain conformations. A crude model where all the CDRs are grafted from template structures can be provided in a few minutes, and high-resolution models can be generated by the full RosettaAntibody protocol running on a cluster of computers in about a day (sometimes users may need to wait for other jobs in the queue). The 10 top-scoring RosettaAntibody models can be used in docking techniques such as EnsembleDock ([@B9]) that can select binding competent conformers during docking.

A few limitations of RosettaAntibody have been that (i) execution of multiple scripts for the identification of templates can be complex, (ii) finding the template structures that have been used in modeling can be challenging given the large number of intermediate files that are generated (iii) the Rosetta command-line interface can be difficult to use and (iv) it requires significant computational time to generate all-atom models, requiring a cluster of computers. To overcome these limitations and to make the high-resolution modeling available to a broader community, we have developed the RosettaAntibody server (<http://antibody.graylab.jhu.edu>), where the interface is simple and modest computing resources are provided.

PROCESSING METHOD
=================

RosettaAntibody predicts the structure of the F~V~ region in two stages. The first stage identifies the CDR loops and the framework regions in the input sequences, chooses the most sequence homologous templates for each respective segment, grafts the template CDRs onto template frameworks, and finally optimizes the side chains of all the residues in the assembled model. The crude model generated in the first stage is used as an input to the second stage.

The second stage of RosettaAntibody is a multi-start, multi-scale Monte Carlo-plus-minimization algorithm that generates two thousand candidate structures. The second stage of the algorithm is split into a low-resolution and a high-resolution phase. The low-resolution phase represents side chains as single pseudo-atoms ([@B10]) and generates candidate CDR H3 loop conformations via fragment assembly and cyclic coordinate descent ([@B11]) in a Monte Carlo loop. Scoring in the low-resolution phase favors nonlocal properties of native protein structures such as hydrophobic burial, compactness, pairing of β-strands and closure of the chain gap during loop building ([@B12]). The high-resolution phase iteratively performs the following: (i) optimizes side chains via rotamer packing and continuous minimization ([@B13]), (ii) perturbs CDR backbone torsion angles and the relative orientation of the light and heavy chains, and (iii) uses gradient-based minimization over the CDR torsion angles and the light chain-heavy chain displacement. The high-resolution energy function includes van der Waals energy, orientation-dependent hydrogen bonding ([@B14]), implicit Gaussian solvation ([@B15]), side-chain rotamer propensities ([@B16]), and a low-weighted distance-dependent dielectric electrostatic energy ([@B17]). Complete methodological details are provided in ref. ([@B7]).

INPUTS AND OUTPUTS
==================

Input
-----

Amino-acid sequences of the light and heavy chains of the F~V~ region are submitted to the server by either pasting the sequences in the appropriate field or by uploading them as two separate FASTA formatted files. Since the RosettaAntibody server models only the F~V~ region of the antibody, F~C~ and leader sequences should be truncated from the input sequence prior to submission. To uniquely identify each job, the user must specify the name of the antibody and can optionally specify the user\'s name and an email address for notification when the modeling task has finished.

Output
------

[Figure 1](#F1){ref-type="fig"} shows a representative output page from the RosettaAntibody server. The top of the page summarizes the details of the respective job, e.g. the name of the antibody, the name of the user (if provided), and the date and time of submission, execution and completion. A chart shows the boundaries of the CDR loops and the framework regions. Next, a table displays the most sequence-homologous template \[identified by BLAST ([@B18])\] for each antibody segment (V~H~ and V~L~ frameworks, CDRs L1, L2, L3, H1, H2 and H3). In a series of selectable panes, the table also displays the top seven templates for each antibody segment. A picture of the crude F~V~ model, formed by joining the top templates, is shown next on the output page with a link for downloading a file containing the coordinates and various energies. Residue numbering of all models generated by RosettaAntibody follows Chothia\'s antibody numbering scheme ([@B19]). Figure 1.Sample results page provided by the server for monoclonal antibody 14B7 ([@B49]). Inset shows the overlay of the 10 top-scoring RosettaAntibody models which appears further down the page (antibody framework regions, gray; light chain CDRs, green; CDRs H1 and H2, blue; CDR H3, red). Web page images are generated with MolScript ([@B50]).

If requested, the next section of the page will show the 10 top-scoring high-resolution structures in rank order by energy. Each model output file includes the scoring data of individual energy terms (van der Waals, solvation, hydrogen bonding energies, etc.) for the whole F~V~ model as well as residue-by-residue breakdowns. Finally, the web page shows a picture of a superposition of the 10 top-scoring structures from the perspective of an antigen, demonstrating the differences in the different models (figure inset).

Any difficulties in processing the sequence would be shown in a 'warnings' section. Warnings sometimes arise to indicate poor matching of template structures or broken predicted CDR H3 loop conformations, resulting in a lower confidence model. Additional explanations of the warnings are provided in the website documentation. The documentation page also explains all output in detail, including a description of the scoring terms found in the coordinate files.

SYSTEM ARCHITECTURE
===================

The RosettaAntibody server has a front-end web process which interfaces with the computation daemon and engine. The front-end, implemented in Python using Django (<http://www.djangoproject.com>), provides results upon request for users and enters modeling tasks into a MySQL database once an input file is submitted. A back-end daemon pulls tasks from the queue in the MySQL database, translates the modeling task into Perl wrapper scripts that detect the different segments of the antibody variable region, runs BLAST to detect templates, specifies a Rosetta++ command-line, and finally submits a job to a Condor (<http://www.cs.wisc.edu/condor>) queue. Condor runs the job on our 188-processor Linux cluster at Johns Hopkins University, as time is available. The back-end daemon periodically detects the status of the job to report, and eventually enters the complete set of results into the MySQL database.

SERVER PERFORMANCE
==================

Since the RosettaAntibody web server opened in December of 2007, over 100 individuals have used the web server for more than 400 modeling jobs. Jobs typically require about 1700 processor-hours, and results are typically complete within a day of submission, although the time will vary with the current cluster load and server queue. The website is free and open to all users with no login requirement.

Validation of the RosettaAntibody server algorithm
--------------------------------------------------

In a large scale test of RosettaAntibody, the program was used to recover the native crystal structures of 54 antibodies ([@B7]). To simulate blind prediction, when database information was used in modeling, only nonrelated (less than 90% sequence identity) antibody structures in the Protein Data Bank ([@B20]) were used. For the best ranked model of each target, the median root mean square deviation (rmsd) of the antigen binding pocket comprising of all the CDR residues was 1.5 Å, and 80% of the targets had an rmsd lower than 2.0 Å.

The loop modeling capabilities of RosettaAntibody were tested by *ab initio* modeling of the CDR H3 loop. The CDR H3 loop is composed of residues 95--102 of the heavy chain \[Chothia numbering ([@B19])\]. The median backbone heavy atom global rmsd of the CDR H3 loop prediction for the best ranked model was 1.6, 1.9, 2.4, 3.1 and 6.0 Å, respectively, for very short (4--6 residues), short (7--9 residues), medium (10--11 residues), long (12--14 residues) and very long (17--22 residues) loops.

Finally, a practical measure of the accuracy of the antibody structures is their utility for docking to antigens. While the inclusion of the RosettaAntibody refinement steps had a small effect on homology modeling rmsds (other than CDR H3), refinement was critical for achieving docking accuracy ([@B7]). When the set of 10 top-scoring RosettaAntibody F~V~ homology models was used in local ensemble docking to antigen, a moderate-to-high accuracy docking prediction \[rated by Critical Assessment of PRediction of Interactions criteria ([@B21])\] was achieved in 7 of 15 targets ([@B7]).

In a comparison of WAM and RosettaAntibody ([@B7]), for some antibodies, the CDR H3 predicted by WAM was closer to the native structure than that of the top-scoring model produced by RosettaAntibody. However, there was typically a more accurate structure among the 10 top-scoring RosettaAntibody models. Furthermore, antibody--antigen docking simulations starting with RosettaAntibody F~V~ models consistently resulted in more accurate docking predictions than those obtained by starting with WAM generated models or unrefined RosettaAntibody models ([@B7]).

Potential uses of the RosettaAntibody server
--------------------------------------------

Antibody structures can be used to guide rational efforts to enhance stability ([@B22],[@B23]) or to humanize sequences to minimize immunological response ([@B24],[@B25]). Antibody structures can also be used for docking to their antigens, either for epitope mapping ([@B26]) or for high-resolution refinement ([@B27]). For example, we docked models of monoclonal antibody 14B7 to the anthrax toxin protective antigen ([@B2]). The models helped us form hypotheses about the mechanism of affinity maturation of several variants of 14B7. Several other instances of docking antibody homology models are present in the literature ([@B28; @B29; @B30]). Docking calculations can be done on several publicly available servers ([@B31; @B32; @B33; @B34; @B35; @B36; @B37; @B38]) including the RosettaDock Server (local docking only for high-resolution refinement, <http://rosettadock.graylab.jhu.edu>) ([@B39]).

Docking of homology models is necessarily less accurate than docking of crystal structures. Experimental information can be used to mitigate errors. For example, we used computational mutagenesis and hotspot analysis to evaluate models of epidermal growth factor receptor binding to mAb 806 ([@B1]). In recognition of the errors present in homology models, RosettaAntibody provides 10 alternate low-energy structures. There are several new docking methods which can use multiple input structures for one of the docking partners ([@B40; @B41; @B42; @B43]). Our EnsembleDock program ([@B9]) can improve low-energy docking solutions, and sometimes the low-energy docking solution is formed by the component homology structure that is closest to the crystal structure.

FUTURE DIRECTIONS
=================

Accurate loop modeling remains one of the central challenges of antibody modeling. Thus, future improvements might be made as better and more efficient loop modeling algorithms \[e.g. kinematic loop closure ([@B44]) or hierarchical local optimization ([@B45],[@B46])\] become available. Predictions might also be improved by inclusion of NMR constraints to bias simulations \[e.g. ([@B47])\]. Some researchers are pursuing therapeutics based 'heavy chain only' (VHH) antibodies discovered in the blood of camelids ([@B48]). VHHs are also easy to clone and express, and their structure might be amendable to prediction, although tests are required to assess the use of standard antibody database. Finally, we are currently developing flexible backbone antibody docking techniques which exploit the same antibody structural modeling tools as the server. These induced-fit antibody docking techniques may additionally help overcome homology modeling errors as predicted structures are used for high-resolution applications.

SUPPLEMENTARY DATA
==================

[Supplementary Data](http://nar.oxfordjournals.org/cgi/content/full/gkp387/DC1) are available at NAR Online.
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